[Inoa Latina] Sambucus nigra

[Specification] Anthocyanidins15% 25% UV

[Hōʻike] ʻulaʻula pauda maikaʻi

Māhele Mea kanu: Hua

[Particle nui] 80Mesh

[Nalo ma ka maloʻo ʻana] ≤5.0%

[Mea Kaumaha] ≤10PPM

[Storage] E kūʻai ma kahi maloʻo a maloʻo, e mālama i ka mālamalama pololei a me ka wela.

[Ke ola mau] 24 Mahina

[Package] Hoʻopili ʻia i loko o nā pahu pahu pepa a me ʻelua ʻeke plastik i loko.

[Kapaona paona] 25kgs/pahu

[He aha ka elderberry extract?]

ʻO Elderberry extract mai ka hua o ka Sambucus nigra a i ʻole ʻEleʻele ʻeleʻele, kahi ʻano i loaʻa ma ʻEulopa, Western Asia, North Africa, a me ʻAmelika ʻĀkau. Kapa ʻia ʻo "ka pahu lāʻau lapaʻau o ka poʻe maʻamau," ua hoʻohana ʻia nā pua kahiko, nā hua, nā lau, ka ʻili, a me nā aʻa no nā kenekulia i nā lāʻau lapaʻau kuʻuna. nā ʻakika amino. Manaʻo ʻia ʻo Elderberry e loaʻa nā hoʻohana therapeutic ma ke ʻano he anti-inflammatory, diuretic, a me ka immuno-stimulant.

[Hana]

1. Ma keʻano he lāʻau lapaʻau maka: Hiki iā ia ke hoʻoikaika i ka ho'ōlaʻana i nā maʻi maʻi'ōpū; Hiki ke hoʻohana ʻia no ka maʻi hepatomegaly evocable, hepatocirrhosis; paipai i ka hoola ana i ka hana o ke ake.

2. E like me ka meaʻai kala: Hoʻohana nui ʻia i nā keke, mea inu, candy, ice cream etc.

3. E like me ka mea kemika no ka hoʻohana ʻana i kēlā me kēia lā: Hoʻohana nui ʻia i nā ʻano lāʻau lapaʻau ʻōmaʻomaʻo toothpastes a me nā mea hoʻonaninani.

Eia ka papa inoa o na kanaka….
Methadone-waha 80-90%, hapalua ola- 24-36 hola, rectal 76%
ʻO ketobemiodone waha he 34% +/-10%, pololei 44% +/- 9%, ʻo ka hapalua o ke ola he 2.25-2.45 mau hola
ʻO ka bioavailability meperidine rectal ma kahi o 55%, 80% a 85% IM, hoʻopau i ka hapalua o ke ola 3.0 h
ʻO ka Buprenorphine ka nui o ka protein i hoʻopaʻa ʻia he 96%, sublingual bioavailability ma kahi o 30%, waha he 15-22%, 90-100% IM, elimination half-life he 12-44 hola.
Hydromorphone- 5-8 mau manawa e like me ka morphine, intranasal- 52.4%, Rectal administration 33%, Oral-30-35%, (i hōʻike pū ʻia he 50.7% +/- 29.8% waha; 33% +/- 22% rectal; 54.4% - 59.8% ihu)
Dihydrocodeine waha-20-21% hapalua hola 4 hola
Heroin waha ~35% IV- 100% IM-85% Puhi (a mahu paha?) 52-55% vaporized Semisynthetic derivative, Intranasal 44-61%
Fentanyl- Bioavailability 92% (transdermal), 50% (sublingual/buccal (kūʻē i ka pāpālina), Protein paʻa 80-85%, hapalua-ola 3-12 hola
Sufentanil intranasal bio- 78%,
ʻO Remifentanil Protein hoʻopaʻa 70% (paʻa i nā protein plasma) Ka hapalua o ke ola 1-20 mau minuke
ʻO Alfentanil- IV ~ 100%, 92% ka hoʻopaʻa ʻana i ka protein, ʻo ka hapalua o ke ola he 1.5-2 mau hola
ʻO Morphine ~ 32% oral/rectal, insuffulated- 15-20%, Chitosan (kahi linear polysaccharide e kōkua maikaʻi i nā lāʻau lapaʻau) ua hōʻike ʻia e hoʻonui i ka bioavailability o ka ihu o ka morphine mai kahi o 10-20% a ma luna o 60%, SC-60% , ka pilina o ka protein 30-40%, ka hapalua o ke ola he 2-3 mau hola
Oxycodone-waha 60-87% intranasal- ʻokoʻa ākea 45-70%
ʻAʻole ʻike maoli ʻia ka bioavailability o ka hydrocodone-oral akā ua puni ia i ka bioavailability oxycodone, ~ 70% o ka mea maʻamau e komo, ʻo ka hapalua o ke ola he 4-8 mau hola.
Oxymorphone nasal bioavailabilty [43%] waha haʻahaʻa 10-20%
Butorphanol -waha 5-17% ma muli o ke kiʻekiʻe mua mua metabolism
Tramadol- ʻo ka bioavailability piha o ka tramadol i hoʻopaʻa ʻia i loko o nā suppositories he 77.0%, Oral-68-72% (Hoʻonui me ka hoʻonui pinepine ʻana) Ka hapalua o ke ola 5-7 hola
Codeine- ma hope o ka hoʻoponopono ʻana a i ʻole ka waha me ka loaʻa ʻana o ka ʻōnaehana ma kahi o 90%; i loko o hoʻokahi haʻawina hoʻomaʻamaʻa ʻokoʻa 4-fold a me ka loaʻa ʻana o ka ʻōnaehana ma hope o ka waha waha ma waena o 50 a me 84%
Diphenoxylate Protein hoʻopaʻa 74-95% Ka hapalua o ke ola 12-14 hola i hoʻohana ʻia no ka maʻi paʻi, (ʻaʻole i ʻoi aku ka maikaʻi ma ke ala o ka pale koko-lolo)
ʻO ka Pethidine(meperidine) Absorption ʻO ka bioavailability waha he 50-60% i nā maʻi me ka hana hepatic maʻamau. IM 80-85%, Hoʻopaʻa Protein 65-75%, Hapa Ola 3-5 hola
ʻO ka Normeperidine ka hapalua o ka ikaika e like me ka meperidine, akā ʻelua ka hopena o ka CNS stimulation.
Pentazocine- Bioavailability ~ 20% waha, Half-ola 2 a 3 hola

ʻOpiate Antagonists
Naloxone waha- 2-4% (90% absorption akā kiʻekiʻe mua-pass metabolism), Hapa ola 1-1.5 hola
Naltrexone Oral Bioavailability 5-40%, Protein binding 21%, Half life-4 hola (naltrexone),
a me 13 hola (6-β-naltrexol) (metabolite)

He polokalamu ola maikaʻi ʻo OMS e manaʻo nei e kōkua i ka poʻe e ola lōʻihi, ola olakino ʻole me nā pilikia maʻamau e pili ana me Multiple Sclerosis. Hoʻokumu ʻia ʻo OMS ma ka noiʻi ʻepekema ikaika. No ka ʻike hou aku e pili ana i ka papahana OMS, e nānā www.overcomingms.org a me ka puke a Professor George Jelinek, 'Overcoming Multiple Sclerosis'.